Global Health Ventures Completes the European Clinical Trials With Lead Therapeutic Drug X-Excite Against Pfizer's Viagra(R)
March 08, 2011 09:04 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, March 8, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company focused on sublingual (under the tongue) drug delivery, is...
Global Health Ventures Announces Start of European Clinical Trials for X-Excite
February 23, 2011 09:18 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, Feb. 23, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company focused on sublingual (under the tongue) drug delivery, is...
Global Health Ventures Inc. Appoints Premier Media Service for Investor
January 05, 2011 13:51 ET
|
Global Health Ventures Inc.
VANCOUVER, British Columbia, Jan. 5, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV) - a specialty pharmaceutical company with expertise in drug delivery and formulation - announced...